Pharmacokinetic considerations in treating invasive pediatric fungal infections-Reference-Cited by-同舟云学术

Pharmacokinetic considerations in treating invasive pediatric fungal infections

Published:2016-05-05 Issue:6 Volume:12 Page:645-655
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Goldman Jennifer L.¹²³⁴,Abdel-Rahman Susan M.¹⁴

Affiliation:

1. Department of Pediatrics, UMKC School of Medicine, Kansas City, MO, USA

2. Drug Safety Service Children’s Mercy Hospital, Kansas City, MO, USA

3. Antimicrobial Stewardship Program Children’s Mercy Hospital, Kansas City, MO, USA

4. Divisions Pediatric Infectious Diseases & Clinical Pharmacology, Toxicology, and Therapeutic Innovation Children’s Mercy Hospital, Kansas City, MO, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2016.1181752

Reference139 articles.

1. Fungal Infections in Children With Cancer

2. Pharmacokinetics and Tissue Penetration of Fluconazole in Humans

3. Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype

4. Single-Ascending-Dose Pharmacokinetics and Safety of the Novel Broad-Spectrum Antifungal Triazole BAL4815 after Intravenous Infusions (50, 100, and 200 Milligrams) and Oral Administrations (100, 200, and 400 Milligrams) of Its Prodrug, BAL8557, in Healthy Volunteers

5. Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Itraconazole Dosing and Drug Monitoring at a Tertiary Children’s Hospital;Pediatric Infectious Disease Journal;2019-01